tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB

Biogen (BIIB) Cash flow

4,076 Followers

Biogen Cash Flow

BIIB's free cash flow for Q3 2023 was $714.50M. For the 2023 fiscal year, BIIB's free cash flow was decreased by $-2.25B and operating cash flow was $1.05B. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ 1.81B$ 1.38B$ 3.64B$ 4.23B$ 7.08B$ 6.19B
Investing Cash Flow
$ -4.54B$ 1.58B$ -563.70M$ -608.60M$ 470.50M$ -2.05B
Financing Cash Flow
$ 744.60M$ -1.75B$ -2.09B$ -5.27B$ -5.86B$ -4.47B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 11.20B$ 3.48B$ 2.26B$ 1.33B$ 2.91B$ 1.22B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
$ 837.30M--$ 2.97B$ 0.00$ 0.00
Repayment Of Debt
$ -159.90M--$ -1.50B$ 0.00$ -3.20M
Free Cash Flow
$ 1.24B$ 1.14B$ 3.39B$ 3.68B$ 6.41B$ 5.30B
Domestic Sales
------
Foreign Sales
------
Currency in USD

Biogen Cash Flow


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis